Anti-DLG5/ LP-DLG/ P-DLG5 monoclonal antibody

Anti-DLG5/ LP-DLG/ P-DLG5 antibody for FACS & in-vivo assay

Target products collectionGo to DLG5/DLG5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2082-Ab-1/ GM-Tg-hg-MP2082-Ab-2Anti-Human DLG5 monoclonal antibodyHuman
GM-Tg-rg-MP2082-Ab-1/ GM-Tg-rg-MP2082-Ab-2Anti-Rat DLG5 monoclonal antibodyRat
GM-Tg-mg-MP2082-Ab-1/ GM-Tg-mg-MP2082-Ab-2Anti-Mouse DLG5 monoclonal antibodyMouse
GM-Tg-cynog-MP2082-Ab-1/ GM-Tg-cynog-MP2082-Ab-2Anti-Cynomolgus/ Rhesus macaque DLG5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2082-Ab-1/ GM-Tg-felg-MP2082-Ab-2Anti-Feline DLG5 monoclonal antibodyFeline
GM-Tg-cang-MP2082-Ab-1/ GM-Tg-cang-MP2082-Ab-2Anti-Canine DLG5 monoclonal antibodyCanine
GM-Tg-bovg-MP2082-Ab-1/ GM-Tg-bovg-MP2082-Ab-2Anti-Bovine DLG5 monoclonal antibodyBovine
GM-Tg-equg-MP2082-Ab-1/ GM-Tg-equg-MP2082-Ab-2Anti-Equine DLG5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2082-Ab-1/ GM-Tg-hg-MP2082-Ab-2; GM-Tg-rg-MP2082-Ab-1/ GM-Tg-rg-MP2082-Ab-2;
GM-Tg-mg-MP2082-Ab-1/ GM-Tg-mg-MP2082-Ab-2; GM-Tg-cynog-MP2082-Ab-1/ GM-Tg-cynog-MP2082-Ab-2;
GM-Tg-felg-MP2082-Ab-1/ GM-Tg-felg-MP2082-Ab-2; GM-Tg-cang-MP2082-Ab-1/ GM-Tg-cang-MP2082-Ab-2;
GM-Tg-bovg-MP2082-Ab-1/ GM-Tg-bovg-MP2082-Ab-2; GM-Tg-equg-MP2082-Ab-1/ GM-Tg-equg-MP2082-Ab-2
Products NameAnti-DLG5 monoclonal antibody
Formatmab
Target NameDLG5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DLG5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DLG5/ LP-DLG/ P-DLG5 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2082
    Target NameDLG5
    Gene ID9231,71228,305645,703123,489061,101093803,535699,100072996
    Gene Symbol and Synonyms4933429D20Rik,DLG5,LP-DLG,mKIAA0583,P-DLG5,PDLG
    Uniprot AccessionQ8TDM6
    Uniprot Entry NameDLG5_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000151208
    Target ClassificationN/A

    The target: DLG5, gene name: DLG5, also named as LP-DLG, P-DLG5, PDLG. This gene encodes a member of the family of discs large (DLG) homologs, a subset of the membrane-associated guanylate kinase (MAGUK) superfamily. The MAGUK proteins are composed of a catalytically inactive guanylate kinase domain, in addition to PDZ and SH3 domains, and are thought to function as scaffolding molecules at sites of cell-cell contact. The protein encoded by this gene localizes to the plasma membrane and cytoplasm, and interacts with components of adherens junctions and the cytoskeleton. It is proposed to function in the transmission of extracellular signals to the cytoskeleton and in the maintenance of epithelial cell structure. Alternative splice variants have been described but their biological nature has not been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.